Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

High-Flow Nasal Cannula on Exercise Tolerance in Heart Failure Patients Undergoing Cardiac Rehabilitation.

NCT: NCT07613762 · NOT_YET_RECRUITING

NCT IDNCT07613762
StatusNOT_YET_RECRUITING
Start Date2026-06-01
Completion2027-03

Brief Summary

The goal of this clinical trial is to learn if a high-flow nasal cannula (HFNC) - a device that delivers warm, humidified air through a small tube placed in the nostrils - can improve exercise tolerance in adults with heart failure who are entering a cardiac rehabilitation program. The main questions it aims to answer are: * Can HFNC help people with heart failure exercise for a longer time during a treadmill test? * Does HFNC lower how hard people feel they are working during exercise? Researchers will compare exercise performance with HFNC to exercise performance without HFNC to see if HFNC helps people with heart failure tolerate exercise better. Participants will: * Complete two treadmill exercise tests, one with HFNC and one without, in a randomly assigned order * Wait 48 to 72 hours between the two tests to allow full recovery * Have their heart rate, blood pressure, oxygen level, and breathing rate measured before and after each test

Frequently Asked Questions

What is High-Flow Nasal Cannula on Exercise Tolerance in Heart Failure Patients Undergoing Cardiac Rehabilitation.?

High-Flow Nasal Cannula on Exercise Tolerance in Heart Failure Patients Undergoing Cardiac Rehabilitation. is a clinical trial registered under NCT07613762. Current status: NOT_YET_RECRUITING.

What is the status of NCT07613762?

The current status of NCT07613762 (High-Flow Nasal Cannula on Exercise Tolerance in Heart Failure Patients Undergoing Cardiac Rehabilitation.) is: NOT_YET_RECRUITING.

When did High-Flow Nasal Cannula on Exercise Tolerance in Heart Failure Patients Undergoing Cardiac Rehabilitation. start?

High-Flow Nasal Cannula on Exercise Tolerance in Heart Failure Patients Undergoing Cardiac Rehabilitation. started on 2026-06-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.